Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection
โ Scribed by Martin J. Edelman; Julie Schuetz
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 292 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC
A prospective randomized trial compared the administration of intrapleural plus intravenous Corynebacterium parvum (C. parvum) versus placebo in patients with resected Stage I and Stage II non-small cell bronchogenic carcinoma. Treatment consisted of 7 mg C. parvum injected into the pleural space an